Real-World Clinician- and Patient-Reported Outcomes and Treatment Persistence Following Bimekizumab Initiation in Patients with Psoriasis: 6-Month Results from the PPD CorEvitas Psoriasis Registry. (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s632. https://doi.org/10.25251/6744kd41